One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says

Follow Drugslib on

By HealthDay Staff HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on April 16, 2026.

via HealthDay

THURSDAY, April 16, 2026 — A widely used anxiety medication is being pulled from shelves due to "failed dissolution specifications," the U.S. Food and Drug Administration (FDA) said.

The agency's enforcement report said that one lot of Xanax has been recalled nationwide by the company Viatris.

The recall, issued March 17, affects lot number 8177156. The bottles contain 60 tablets of the 3-milligram extended-release version of the prescription drug, with an expiration date of Feb. 28, 2027.

The problem, according to NBC Chicago, is that the tablets may not break down and release the drug into the body as intended.

This could make the medication less effective or lead to inconsistent dosing, officials explained.

The recall has been classified as Class II, meaning use of the product “may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote,” the FDA said.

The number of bottles affected is not known, NBC Chicago said.

Sources

  • NBC Chicago, April 15, 2026
  • U.S. Food and Drug Administration, enforcement report, April 8, 2026

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2026-04-17 02:06

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords